Cargando…

First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia

BACKGROUND: First trimester Pregnancy Associated Plasma Protein A (PAPP-A) levels, routinely measured for aneuploidy screening, may predict development of preeclampsia. This study tests the hypothesis that first trimester PAPP-A levels correlate with soluble fms-like tyrosine kinase-1 (sFlt-1) level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saxena, Aditi R, Seely, Ellen W, Rich-Edwards, Janet W, Wilkins-Haug, Louise E, Karumanchi, S Ananth, McElrath, Thomas F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623663/ https://www.ncbi.nlm.nih.gov/pubmed/23557166 http://dx.doi.org/10.1186/1471-2393-13-85

Ejemplares similares

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia
por: Bian, Zheng, et al.
Publicado: (2015)

Carbon Monoxide Prevents Hypertension and Proteinuria in an Adenovirus sFlt-1 Preeclampsia-Like Mouse Model
por: Venditti, Carolina C., et al.
Publicado: (2014)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination
por: Hagmann, Henning, et al.
Publicado: (2014)

Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia
por: Souders, Colby A., et al.
Publicado: (2015)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Tataru-Copos, Anca-Florina, et al.
Publicado: (2022)

Predicting Preeclampsia Pregnancy Termination Time Using sFlt-1
por: Tanaka, Hiroaki, et al.
Publicado: (2022)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020)

A simple detection method for the serum sFLT1 protein in preeclampsia
por: Shibuya, Masabumi, et al.
Publicado: (2021)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population
por: Kumar, Namrata, et al.
Publicado: (2023)

MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia
por: Yong, Qing, et al.
Publicado: (2023)

Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase
por: Oe, Yuji, et al.
Publicado: (2018)

Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1
por: Davis, Sarah M., et al.
Publicado: (2022)

PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?
por: Moslemi Zadeh, Narges, et al.
Publicado: (2012)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
por: Nikuei, Pooneh, et al.
Publicado: (2020)

FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia
por: Ashar-Patel, Ami, et al.
Publicado: (2017)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
por: Miyatake, Risa, et al.
Publicado: (2023)

Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2007)

Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia
por: Chen, Xinhua, et al.
Publicado: (2019)

Influential Serum Kinases (Non-sFlt-1) and Phosphatases in Preeclampsia—Systematic Review and Metanalysis
por: Marrufo-Gallegos, Karla Cecilia, et al.
Publicado: (2023)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
por: Kozłowski, Szymon, et al.
Publicado: (2021)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
por: Pant, Vivek, et al.
Publicado: (2019)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
por: Schlembach, Dietmar, et al.
Publicado: (2018)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia
por: Klein, Evelyn, et al.
Publicado: (2016)

Nested Case–Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia
por: Liu, Mei, et al.
Publicado: (2021)

Association of sFlt-1 and C-reactive protein with outcomes in severe preeclampsia: A cohort study
por: Nóbrega, Leandro, et al.
Publicado: (2022)

Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)
por: Velegrakis, Alexandros, et al.
Publicado: (2023)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
por: Penka, Lukas, et al.
Publicado: (2020)

Evaluation of serum β-hCG and PAPP-A levels in pregnant women at risk of developing preeclampsia
por: OANCEA, MIHAELA DANIELA, et al.
Publicado: (2013)

Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia
por: Tong, Mancy, et al.
Publicado: (2017)

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
por: Iriyama, Takayuki, et al.
Publicado: (2019)

Oxidative and Inflammatory Imbalance in Placenta and Kidney of sFlt1-Induced Early-Onset Preeclampsia Rat Model
por: Santana-Garrido, Álvaro, et al.
Publicado: (2022)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies
por: Giardini, Valentina, et al.
Publicado: (2023)

First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring
por: Fruscalzo, Arrigo, et al.
Publicado: (2020)

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM)
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2019)

Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2018)

Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1–Induced Preeclampsia Phenotype in Mice
por: Zhang, Shenghong, et al.
Publicado: (2018)

Relationship between the sFlt-1/PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia
por: Lee, Jaekyoung, et al.
Publicado: (2021)

Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management
por: Nobrega, Guilherme M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6khjbob9dkn52dov4int8c6rmo